Ruthenium(II) pyridine functionalized NHC complexes
(C, t Bu), 19.4 (C, t Bu), 14.2 (C, t Bu); ESI: m/z calcd.
For C12H16N3Br [M–Br]+, 202.28; Found, [M–Br]+,
202.08.
CH2Cl2, and precipitated with pentane to give pyridine-
functionalized imidazolium salt (1a–d) as a pale yellow
powder in good yield.
2.5a Compound 1a (R =Ph): The synthetic proce-
dure of this compound was same as that of the above
representative procedure, using 1-phenyl imidazole to
give a pale yellow solid 1a. Yield: 91%; M.p. 79–82◦C;
Anal. Calcd(%) for C14H12N3Br: C, 55.65; H, 4.00;
2.5d Compound 1d (R = Mes): The synthetic proce-
dure of this compound was the same as that of above
representative procedure, using 1-mesityl imidazole to
give a pale yellow solid 1d. Yield: 91%; M.p. 72–75◦C;
Anal. Calcd(%) for C17H18N3Br: C, 59.31; H, 5.27;
1
1
N, 13.91. Found(%): C, 55.81; H, 4.33; N, 13.62; H
N, 12.21. Found(%): C, 59.07; H, 5.41; N, 12.39; H
NMR (300.13 MHz, CDCl3): δ 11.4 (1H, s, NCHN),
8.6 (1H, d, J= 8.1 Hz, Py–H), 8.3 (1H, m, Py–H), 8.3
(1H, t, imi–H), 8.0 (1H, m, Py–H), 7.9 (1H, t, imi–H),
7.7-7.4 (5H, m, Ar–H), 7.4 (1H, m, Py–H); 13C NMR
(75.47 MHz, CDCl3): δ 154.2 (C=N), 149.1 (NCHN),
130.4 (Ar–C), 129.4 (Ar–C), 127.9 (Ar–C), 125.9 (Ar–
C), 123.6 (imi–C), 122.0 (Ar–C), 119.4 (imi–C), 117.2
(Ar–C), 115.3 (Ar–C), 114.6 (Ar–C); ESI: m/z calcd.
For C14H12N3Br [M–Br]+, 222.23; Found, [M–Br]+,
222.17.
NMR (300.13 MHz, CDCl3): δ 11.2 (1H, s, NCHN),
8.6 (1H, d, J= 8.0 Hz, Py–H), 8.3 (1H, m, Py–H),
8.2 (1H, t, imi–H), 8.1 (1H, m, Py–H), 7.9 (1H, t, imi–
H), 7.7 (1H, m, Py–H), 2.4 (3H, s, CH3), 2.2 (6H, s,
CH3); 13C NMR (75.47 MHz, CDCl3): δ 152.4 (C=N),
149.4 (NCHN), 129.3 (Ar–C), 126.7 (Ar–C), 123.2
(imi–C), 120.1 (imi–C), 119.5 (Ar–C), 117.4 (Ar–C),
30.2 (CH3), 28.5 (CH3), 28.2 (CH3); ESI: m/z calcd.
For C17H18N3Br [M–Br]+, 264.35; Found, [M–Br]+,
264.17.
i
2.6 Syntheses of Pyridine-functionalized N-heterocyclic
carbene ruthenium(II) complexes (3a-d)
2.5b Compound 1b (R = Pr): The synthetic proce-
dure of this compound was the same as that of above
representative procedure, using 1-isopropyl imidazole
to give a pale yellow solid 1b. Yield: 89%; M.p. 64–
66◦C; Anal. Calcd(%) for C11H14N3Br: C, 49.27; H,
5.26; N, 15.67. Found(%): C, 49.44; H, 5.37; N, 15.83;
1H NMR (300.13 MHz, CDCl3): δ 10.8 (1H, s, NCHN),
8.5 (1H, d, J= 8.2 Hz, Py–H), 8.3 (1H, m, Py–H), 8.2
(1H, t, imi–H), 8.0 (1H, m, Py–H), 7.9 (1H, t, imi–
H), 7.6 (1H, m, Py–H), 4.8 (1H, m, CH(CH3)2), 1.6
(6H, m, CH(CH3)2); 13C NMR (75.47 MHz, CDCl3):
δ 153.4 (C=N), 148.2 (NCHN), 129.9 (Ar–C), 127.5
(Ar–C), 124.5 (imi–C), 122.3 (imi–C), 121.4 (Ar–C),
119.4 (Ar–C), 30.2 (CH3), 29.3 (CH3); ESI: m/z calcd.
For C11H14N3Br [M–Br]+, 188.25; Found, [M–Br]+,
188.17.
Pyridine-functionalized imidazolium salts (R= Ph (1a),
iPr (1b), tBu (1c), Mes (1d) (2 mmol) and Silver(I)
oxide (0.231 g, 1 mmol) in 25 mL of dichloromethane
were stirred in dark at room temperature for 24 h.
The unreacted Ag2O was removed by filtration over
a pad of Celite. The resulting yellowish solution was
concentrated to 2 mL then Et2O was added to pre-
cipitate the product as a white, flaky solid. The solid
was isolated, washed with Et2O (3 × 5 mL), and
dried under reduced pressure to yield the correspond-
ing Ag–NHC complexes as an off-white solid. To the
dichloromethane solution (15 mL) of Ag–NHC com-
plex, [RuHCl(CO)(PPh3)3] (0.9524 g, 1 mmol) was
added, and the mixture was stirred overnight in dark
at room temperature. After filtration through a Celite
plug to remove the AgBr by-product, the solvent was
reduced to 5 mL, and diethyl ether (20 mL) was added
to precipitate the crude product. The resulting crude
product was purified using column chromatography
(SiO2, 10:1 CH2Cl2/acetone).
t
2.5c Compound 1c (R = Bu): The synthetic proce-
dure of this compound was the same as that of above
representative procedure, using 1-tert-butyl imidazole
to give a pale yellow solid 1c. Yield: 91%; M.p.
68–70◦C; Anal. Calcd(%) for C12H16N3Br: C, 51.08;
H, 5.72; N, 14.89. Found(%): C, 51.39; H, 5.83; N,
1
14.62; H NMR (300.13 MHz, CDCl3): δ 11.7 (1H, s,
NCHN), 8.6 (1H, d, J= 8.0 Hz, Py–H), 8.5 (1H, dd, 2.6a Compound 3a (R = Ph): The synthetic procedure
J= 4.8 Hz, J=1.0 Hz, Py–H), 8.3 (1H, t, imi–H), 8.1 of this compound was the same as that of above rep-
(1H, m, Py–H), 7.6 (1H, t, imi–H), 7.3 (1H, dd, J= 7.1 resentative procedure, using 1a to give a yellow solid
t
Hz, J= 4.8 Hz, Py–H), 4.6 (2H, t, Bu), 1.9 (2H, m, 3a. Yield: 76%; M.p. 231–234◦C; Anal. Calcd(%)
t Bu), 1.3 (2H, m, Bu), 0.9 (3H, m, Bu); 13C NMR for C33H27N3OClPRu: C, 61.06; H, 4.19; N, 6.47.
(75.47 MHz, CDCl3): δ 153.2 (C=N), 149.5 (NCHN), Found(%): C, 61.39; H, 4.42; N, 6.12; IR (KBr disks,
141.2 (Ar–C), 136.9 (Ar–C), 129.4 (Ar–C), 127.3 (imi– cm−1); 1974 (C≡O), 1560 (C=C), 1547 (N–C–N),
t
t
t
1
C), 121.1 (imi–C), 115.0 (Ar–C), 50.0 (C, Bu), 39.3 1502 (C–C), 1580 (C=N); H NMR (300.13 MHz,